InvestSMART

USCOM Ltd (ASX: UCM) - Announcements

- Current share price for UCM : $0.012

ASX company news and announcements for USCOM Ltd (UCM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All USCOM Ltd (UCM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than USCOM Ltd (UCM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for USCOM Ltd (UCM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$3 Uscom BP leading blood pressure technology - Global study 10 Feb 2014 10:36AM $0.185 $0.012 fallen by 93.51%
$3 Uscom BP receives CE Mark for sales into Europe 4 Feb 2014 11:33AM $0.145 $0.012 fallen by 91.72%
$3 Uscom appoints Deltex to distribution team 29 Jan 2014 9:59AM $0.140 $0.012 fallen by 91.43%
$3 Appendix 4C - quarterly 29 Jan 2014 9:52AM $0.140 $0.012 fallen by 91.43%
$3 Appendix 4C - quarterly 28 Oct 2013 4:45PM $0.180 $0.012 fallen by 93.33%
$3 Uscom signs 5 year $7m China sales deal 15 Oct 2013 10:07AM $0.170 $0.012 fallen by 92.94%
$3 Successful capital raising to support new sales initiatives 18 Sep 2013 9:34AM $0.180 $0.012 fallen by 93.33%
$3 Preliminary and Annual Report to shareholders 30 Aug 2013 4:27PM $0.200 $0.012 fallen by 94%
$3 Appendix 4C - quarterly 26 Jul 2013 3:24PM $0.180 $0.012 fallen by 93.33%
$3 Uscom Announces Italian Distribution Deal with Vega 25 Jun 2013 9:59AM $0.200 $0.012 fallen by 94%
$3 Uscom Completes Pulsecor Asset Purchase 18 Jun 2013 10:01AM $0.165 $0.012 fallen by 92.73%
$3 Uscom to Acquire Pulsecor and New Blood Pressure Products 30 May 2013 11:27AM $0.210 $0.012 fallen by 94.29%
$3 New USCOM Method for Measurement of Heart Function 8 May 2013 11:41AM $0.210 $0.012 fallen by 94.29%
$3 USCOM Strategic Focus - New Distribution in Mexico 1 May 2013 9:42AM $0.200 $0.012 fallen by 94%
$3 Appendix 4C - quarterly 26 Apr 2013 2:04PM $0.200 $0.012 fallen by 94%
$3 Half Yearly Report and Accounts 27 Feb 2013 4:58PM $0.190 $0.012 fallen by 93.68%
$3 Reduction in Sepsis Deaths and Hospital Costs Using USCOM 22 Jan 2013 10:29AM $0.190 $0.012 fallen by 93.68%
$3 Appendix 4C - quarterly 22 Jan 2013 10:17AM $0.190 $0.012 fallen by 93.68%
$3 USCOM more accurate monitor than blood pressure in pregnancy 23 Oct 2012 9:35AM $0.150 $0.012 fallen by 92%
$3 Appendix 4C - quarterly 17 Oct 2012 1:42PM $0.170 $0.012 fallen by 92.94%
$3 Role for USCOM in cancer treatment 24 Sep 2012 10:47AM $0.170 $0.012 fallen by 92.94%
$3 Sophisticated investors oversubscribe to Uscom placement 5 Sep 2012 9:27AM $0.170 $0.012 fallen by 92.94%
$3 Preliminary and Annual Report to shareholders 30 Aug 2012 2:07PM $0.170 $0.012 fallen by 92.94%
$3 Uscom opens private placement fully subscribed 20 Aug 2012 11:19AM $0.145 $0.012 fallen by 91.72%
$3 Response to ASX Appendix 4C Query 2 Aug 2012 5:05PM $0.120 $0.012 fallen by 90%

501 - 525 of 657 results

Page 21 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.